Karyopharm Therapeutics Inc. Contracts & Agreements

118 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter, dated December 19, 2024, between the Company and Lori Macomber
Karyopharm Therapeutics Inc.
Biotechnology
2025
Sixth Amendment to Lease, dated November 5, 2024, by and between the Company and TCD 234 MA WELLS PROPERTY LLC
Lease Agreements
Karyopharm Therapeutics Inc.
2024
Transition Agreement, dated as of August 29, 2024, between the Company and Michael Mason
Transition Agreements
Karyopharm Therapeutics Inc.
2024
Consulting Agreement, dated as of August 29, 2024, between the Company and Michael Mason
Consulting Agreements
Karyopharm Therapeutics Inc.
2024
Non-Employee Director Compensation Policy
Compensation Agreements
Karyopharm Therapeutics Inc.
2024
Offer Letter, dated as of April 4, 2022, between the Registrant and Reshma Rangwala
Karyopharm Therapeutics Inc.
2024
Karyopharm Therapeutics Inc. Annual Bonus Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2024
Common Stock Purchase Warrant, dated August 1, 2023, issued to Heathcare Royalty Partners III, L.P
Warrant Agreements
Karyopharm Therapeutics Inc.
2023
Second Amendment to Revenue Interest Financing Agreement, dated as of August 1, 2023, by and among the Registrant, Karyopharm Europe GmbH, HealthCare Royalty Partners III, L.P.,...
Management Agreements
Karyopharm Therapeutics Inc.
2023
Karyopharm Therapeutics Inc. Annual Bonus Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2023
Form of Restricted Stock Unit Agreement (Performance Vested) under 2022 Equity Incentive Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2023
Form of Warrant to Purchase Common Stock to be issued pursuant to the Securities Purchase Agreement
Warrant Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2022
Securities Purchase Agreement, dated December 5, 2022, by and among the Company and the other parties thereto
Purchase Agreements
Karyopharm Therapeutics Inc.
2022
Registration Rights Agreement, dated December 5, 2022, by and among the Company and the other parties thereto
Registration Rights Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2022
Form of Incentive Stock Option Agreement under 2022 Equity Incentive Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2022
Form of Restricted Stock Unit Agreement under 2022 Equity Incentive Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2022
Form of Incentive Stock Option Agreement under the 2022 Israeli Equity Incentive Sub Plan to the 2022 Equity Incentive Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2022
Form of Restricted Stock Unit Agreement under the 2022 Israel Equity Incentive Sub Plan to the 2022 Equity Incentive Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2022
Non-Employee Director Compensation Policy dated June 30, 2022
Compensation Agreements
Karyopharm Therapeutics Inc.
2022
Severance agreement, dated August 2, 2022, between the Registrant and Ran Frenkel
Severance Agreements
Karyopharm Therapeutics Inc.
2022
Consulting Agreement, dated August 2, 2022, between the Registrant and Ran Frenkel
Consulting Agreements
Karyopharm Therapeutics Inc.
2022
Severance Agreement, dated February 18, 2022, between the Registrant and Jatin Shah
Severance Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2022
Consulting Agreement, dated March 1, 2022, between the Registrant and Jatin Shah
Consulting Agreements
Karyopharm Therapeutics Inc.
2022
Amendment #1 to Consulting Agreement, dated March 21, 2022, between the Registrant and Jatin Shah
Consulting Agreements
Karyopharm Therapeutics Inc.
2022
Side Letter to Offer Letter, dated October 1, 2020, between the Registrant and Ran Frenkel
Karyopharm Therapeutics Inc.
Biotechnology
2022
Transition Agreement, dated March 28, 2022, between the Company and Michael G. Kauffman
Transition Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2022
Transition Agreement, dated March 28, 2022, between the Company and Sharon Shacham
Transition Agreements
Karyopharm Therapeutics Inc.
2022
Form of Restricted Stock Unit Agreement under 2013 Stock Incentive Plan adopted January 24, 2022
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2022
2022 Inducement Stock Incentive Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2022
Form of Nonstatutory Stock Option Agreement under 2022 Inducement Stock Incentive Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2022
Form of Restricted Stock Unit Agreement under 2022 Inducement Stock Incentive Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2022
License Agreement, dated as of December 17, 2021, between the Registrant and Berlin-Chemie AG (Menarini Group)
License Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2022
Amendment to Asset Purchase Agreement, dated as of July 17, 2019, by and between the Registrant and Biogen MA Inc
Purchase Agreements
Karyopharm Therapeutics Inc.
2021
Non-Employee Director Compensation Policy, dated as of May 12, 2021
Compensation Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2021
Omnibus Amendment to Transaction Documents, dated as of June 23, 2021, by and among the Company, Karyopharm Europe GmbH, Karyopharm Therapeutics (Bermuda) Ltd., HealthCare Royalty...
Karyopharm Therapeutics Inc.
Biotechnology
NY
2021
Offer Letter, dated as of April 28, 2021, between the Company and Richard Paulson
Karyopharm Therapeutics Inc.
2021
Amended and Restated Letter Agreement, dated as of April 28, 2021, between the Company and Michael Kauffman, M.D., Ph.D
Karyopharm Therapeutics Inc.
Biotechnology
2021
Amended and Restated Letter Agreement, dated as of April 28, 2021, between the Company and Sharon Shacham, Ph.D., M.B.A
Karyopharm Therapeutics Inc.
2021
Description of Securities Registered under Section 12 of the Exchange Act
Karyopharm Therapeutics Inc.
2021
Fifth Amendment to Lease, dated as of August 13, 2020, by and between the Registrant and AG-JCM Wells Avenue Property Owner, LLC
Lease Agreements
Karyopharm Therapeutics Inc.
2020
Letter Agreement, dated as of October 1, 2020, between the Registrant and Ran Frenkel
Karyopharm Therapeutics Inc.
2020
Form of Incentive Stock Option Agreement under 2013 Stock Incentive Plan adopted August 25, 2020
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2020
Form of Nonstatutory Stock Option Agreement under 2013 Stock Incentive Plan adopted August 25, 2020
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2020
Form of Restricted Stock Unit Agreement under 2013 Stock Incentive Plan adopted August 25, 2020
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2020
Form of Nonstatutory Stock Option Agreement for Inducement Grants adopted August 25, 2020
Stock Agreements
Karyopharm Therapeutics Inc.
2020
2020 Israeli Equity Incentive Sub Plan to the 2013 Stock Incentive Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2020
Form of Option Agreement under 2020 Israeli Equity Incentive Sub Plan to the 2013 Stock Incentive Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2020
Form of Restricted Stock Unit Agreement under 2020 Israeli Equity Incentive Sub Plan to the 2013 Stock Incentive Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2020
Transition Agreement, dated as of September 25, 2020, between the Company and Christopher B. Primiano
Transition Agreements
Karyopharm Therapeutics Inc.
2020
Consulting Agreement, dated as of September 25, 2020, between the Company and Christopher B. Primiano
Consulting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2020
Amended and Restated Letter Agreement, dated as of August 31, 2020, between the Company and Michael Kauffman, M.D., Ph.D
Karyopharm Therapeutics Inc.
2020
Amended and Restated Letter Agreement, dated as of August 31, 2020, between the Company and Sharon Shacham, Ph.D., M.B.A
Karyopharm Therapeutics Inc.
Biotechnology
2020
Amended and Restated Letter Agreement, dated as of August 31, 2020, between the Company and Christopher B. Primiano
Karyopharm Therapeutics Inc.
Biotechnology
2020
Letter Agreement, dated as of August 31, 2020, between the Company and Michael Mason
Karyopharm Therapeutics Inc.
2020
Amendment to License Agreement, dated May 1, 2020, by and between Antengene Therapeutics Limited and the Registrant
License Agreements
Karyopharm Therapeutics Inc.
2020
Amendment No. 1 to the Open Market Sale Agreement, by and between the Company and Jefferies LLC, dated May 5, 2020
Karyopharm Therapeutics Inc.
2020
Underwriting Agreement, dated March 3, 2020, by and among the Company, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Jefferies LLC
Underwriting Agreements
Karyopharm Therapeutics Inc.
2020
Description of Securities Registered under Section 12 of the Exchange Act
Karyopharm Therapeutics Inc.
2020
Revenue Interest Financing Agreement, dated September 14, 2019, between the Registrant and HealthCare Royalty Partners III, L.P, and HealthCare Royalty Partners IV, L.P
Financing Agreements
Karyopharm Therapeutics Inc.
2019
Karyopharm Therapeutics Inc. Annual Bonus Plan
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2019
Offer Letter, dated February 3, 2019, between the Company and Michael Mason
Karyopharm Therapeutics Inc.
Biotechnology
MA
2019
Nonstatutory Stock Option Agreement, dated February 25, 2019, between the Company and Michael Mason
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2019
Separation Agreement dated January 17, 2019, between the Company and Michael Falvey
Separation Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2019
Consulting Agreement dated January 18, 2019, between the Company and Michael Falvey
Consulting Agreements
Karyopharm Therapeutics Inc.
2019
Retention Agreement dated January 17, 2019, between the Company and Cameron Peters
Retention Agreements
Karyopharm Therapeutics Inc.
2019
Indenture (including form of Note) with respect to the Companys 3.00% convertible senior notes due 2025, dated as of October 16, 2018, between the Company and Wilmington Trust,...
Indenture Agreements
Karyopharm Therapeutics Inc.
2018
Open Market Sale AgreementSM, dated August 17, 2018, by and between Karyopharm Therapeutics Inc. and Jefferies LLC
Karyopharm Therapeutics Inc.
Biotechnology
NY
2018
License Agreement, dated May 23, 2018, by and between Antengene Therapeutics Limited and the Registrant
License Agreements
Karyopharm Therapeutics Inc.
2018
Parent Company Guarantee, dated May 23, 2018, by Antengene Corporation Co. Ltd
Guarantee Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2018
Fourth Amendment to Lease, dated June 6, 2018, by and between the Registrant and AG-JCM Wells Avenue Property Owner, LLC and the Registrant
Lease Agreements
Karyopharm Therapeutics Inc.
2018
Offer Letter, dated June 7, 2018, by and between the Registrant and Anand Varadan
Karyopharm Therapeutics Inc.
2018
Asset Purchase Agreement, dated January 24, 2018, by and between Biogen MA Inc. and the Registrant
Purchase Agreements
Karyopharm Therapeutics Inc.
2018
Third Amendment to Lease, dated February 28, 2018, by and between the Registrant and AG-JCM Wells Avenue Property Owner, LLC
Lease Agreements
Karyopharm Therapeutics Inc.
2018
Form of Nonstatutory Stock Option Agreement for Inducement Grants
Stock Agreements
Karyopharm Therapeutics Inc.
2018
Underwriting Agreement, dated May 2, 2018, by and among the Company, J.P. Morgan Securities LLC, Jefferies LLC and Leerink Partners LLC
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2018
License Agreement, dated October 11, 2017, by and between the Registrant and Ono Pharmaceutical Co., Ltd
License Agreements
Karyopharm Therapeutics Inc.
2018
Amendment No. 2 to Controlled Equity OfferingSM Sales Agreement, dated December 7, 2015, as amended on November 7, 2016, by and between the Company and Cantor Fitzgerald & Co.,...
Sales Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2017
Offer Letter, dated September 9, 2017, between the Company and Michael Falvey
Karyopharm Therapeutics Inc.
2017
Nonstatutory Stock Option Agreement, dated September 11, 2017, between the Company and Mr. Falvey
Stock Agreements
Karyopharm Therapeutics Inc.
2017
KARYOPHARM THERAPEUTICS INC. (aDelaware corporation) 3,902,439 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Karyopharm Therapeutics Inc.
2017
CONSULTING AGREEMENT
Consulting Agreements
Karyopharm Therapeutics Inc.
2017
First Amendment to Letter Agreement
Karyopharm Therapeutics Inc.
2017
KARYOPHARM THERAPEUTICS INC. CONTROLLED EQUITY OFFERINGSM AMENDMENT NO. 1 TO SALES AGREEMENT
Sales Agreements
Karyopharm Therapeutics Inc.
2016
KARYOPHARM THERAPEUTICS INC. Shares of Common Stock (par value$0.0001 per share) Controlled Equity OfferingSM Sales Agreement
Stock Agreements
Karyopharm Therapeutics Inc.
2015
KARYOPHARM THERAPEUTICS INC. RESTRICTED STOCK UNIT AGREEMENT
Stock Agreements
Karyopharm Therapeutics Inc.
2015
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
2015
1. Nachtrag zum Geschäftsführer- Anstellungsvertrag
Karyopharm Therapeutics Inc.
Biotechnology
2015
FIRST AMENDMENT TO CONSULTING AGREEMENT BETWEEN KARYOPHARMTHERAPEUTICS AND MIRZA CONSULTING
Consulting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2015
SECOND AMENDMENT TO LEASE
Lease Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2015
Geschäftsführer-Anstellungsvertrag zwischen
Karyopharm Therapeutics Inc.
Biotechnology
2015
Page 2 of 6
Karyopharm Therapeutics Inc.
Biotechnology
2015
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2015
Vereinbarung über die Änderung eines Geschäftsführer-Anstellungsvertrags
Karyopharm Therapeutics Inc.
Biotechnology
2015
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2015
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2015
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2015
KARYOPHARM THERAPEUTICS INC. (aDelaware corporation) 3,000,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2015
FIRST AMENDMENT TO LEASE
Lease Agreements
Karyopharm Therapeutics Inc.
2015
[Signatures appear on following page]
Karyopharm Therapeutics Inc.
Biotechnology
2014
CONSULTING AGREEMENT
Consulting Agreements
Karyopharm Therapeutics Inc.
2014
KARYOPHARM THERAPEUTICS INC. (a Delaware corporation) [ ] Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2014
OFFICE LEASE AGREEMENT BETWEEN NS WELLS ACQUISITION LLC, a Delaware limited liability company (LANDLORD) AND KARYOPHARM THERAPEUTICS INC., a Delaware corporation (TENANT)
Lease Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2014
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
2014
KARYOPHARM THERAPEUTICS INC. (a Delaware corporation) Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
NY
2013
KARYOPHARM THERAPEUTICS INC. 2013 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2013
KARYOPHARM THERAPEUTICS INC. INCENTIVE STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2013
KARYOPHARM THERAPEUTICS INC. NONSTATUTORY STOCK OPTION AGREEMENT
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
2013
KARYOPHARM THERAPEUTICS INC. 2013 EMPLOYEE STOCK PURCHASE PLAN October 8, 2013
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2013
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
2013
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
2013
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2013
KARYOPHARM THERAPEUTICS INC. THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT July 26, 2013
Investor Rights Agreements
Karyopharm Therapeutics Inc.
2013
KARYOPHARM THERAPEUTICS INC. AMENDED AND RESTATED 2010 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
Karyopharm Therapeutics Inc.
2013
KARYOPHARM THERAPEUTICS INC. NON-QUALIFIED STOCK OPTION AGREEMENT
Stock Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2013
Consulting Agreement
Consulting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2013
CONSULTING AGREEMENT
Consulting Agreements
Karyopharm Therapeutics Inc.
Biotechnology
MA
2013
INDEMNIFICATION AGREEMENT
Indemnification Agreements
Karyopharm Therapeutics Inc.
Biotechnology
DE
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. RESEARCH AGREEMENT
Exchange Agreements
Karyopharm Therapeutics Inc.
2013